Epibiotech Co., Ltd. (XKON:446440)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,000
+1,000 (8.33%)
At close: Aug 8, 2025
36.84%
Market Cap 28.84B
Revenue (ttm) 449.62M
Net Income (ttm) -5.06B
Shares Out 2.31M
EPS (ttm) -2,966.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25
Average Volume 110
Open 11,800
Previous Close 12,000
Day's Range 11,500 - 13,000
52-Week Range 8,600 - 16,500
Beta 1.12
RSI 61.28
Earnings Date n/a

About Epibiotech

Epibiotech Co., Ltd., a biopharmaceutical research company, develops cell and antibody treatments for hair restoration medical needs. The company was formerly known as Stemore Co., Ltd. and changed its name to Epibiotech Co., Ltd. in May 2021. The company was founded in 2015 and is headquartered in Incheon, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2015
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 446440
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.